CVS Health (CVS) Stock Price, News & Analysis

Company Overview

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services. MinuteClinic locations provide walk-in treatment for common illnesses, routine vaccinations, screenings and other basic health care services.

Through Aetna, CVS Health offers a range of health insurance products, including employer-sponsored plans, individual coverage, Medicare and Medicaid offerings. The company also provides primary and value-based care through businesses such as Oak Street Health and Signify Health, which support care delivery and in-home or technology-enabled health assessments.

CVS Health was founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, and expanded from a regional pharmacy retailer into an integrated health care company. The company completed its acquisition of Aetna in 2018, strengthening its presence in health insurance and care coordination. CVS Health is led by President and Chief Executive Officer David Joyner and primarily serves members, patients and customers throughout the United States, including Puerto Rico.

Key Stats

• Today's Range: $87.88 to $90.62
• 50-Day Range: $84.96 to $97.36
• 52-Week Range: $69.51 to $110.68
• Volume: 9.55 million shs
• Average Volume: 8.29 million shs
• Market Capitalization: $113.24 billion
• P/E Ratio: 11.47
• Dividend Yield: 3.00%
• Price Target: $109.64
• Consensus Rating: Moderate Buy

CVS Health Stock Analysis - MarketRank™

CVS Health scored higher than 98% of companies evaluated by MarketBeat, and ranked 3rd out of 894 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on no strong buy ratings, 19 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

CVS Health has a consensus price target of $109.64, representing about 23.8% upside from its current price of $88.54.

Amount of Analyst Coverage

CVS Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 6.11%

Earnings Growth

Earnings for CVS Health are expected to grow by 6.11% in the coming year, from $8.02 to $8.51 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CVS Health is 23.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.99.

Price to Earnings Ratio vs. Sector

The P/E ratio of CVS Health is 23.42, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.81.

Price to Earnings Growth Ratio

CVS Health has a PEG Ratio of 0.84. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

CVS Health has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.28% of the float of CVS Health has been sold short.

Short Interest Ratio / Days to Cover

CVS Health has a short interest ratio ("days to cover") of 1.57, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CVS Health has recently decreased by 1.68%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

CVS Health pays a meaningful dividend of 2.95%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

CVS Health has only been increasing its dividend for 4 years.

Dividend Coverage

The dividend payout ratio of CVS Health is 70.37%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, CVS Health will have a dividend payout ratio of 31.26% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.52

News Sentiment

CVS Health has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 33 news articles for CVS Health this week, compared to 8 articles on an average week.

Search Interest

Only 40 people have searched for CVS on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.

MarketBeat Follows

32 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is an increase of 256% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CVS Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.85% of the stock of CVS Health is held by insiders.

Percentage Held by Institutions

80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/05/2026
• Record date for 11/2 Dividend: 10/22/2026
• Ex-Dividend for 11/2 Dividend: 10/22/2026
• Today: 11/02/2026
• Dividend Payable: 11/02/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:CVS
• CIK: 64803
• Web: www.cvshealth.com
• Phone: (401) 765-1500
• Fax: 401-762-2137
• Employees: 300,000
• Year Founded: 1963

Price Target and Rating

• Average Price Target for CVS Health: $109.64
• High Price Target: $123.00
• Low Price Target: $92.00
• Potential Upside/Downside: +23.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 22 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.78
• Trailing P/E Ratio: 11.47
• Forward P/E Ratio: 10.40
• P/E Growth: 0.84
• Net Income: $1.77 billion
• Net Margins: 1.18%
• Pretax Margin: 1.39%
• Return on Equity: 13.12%
• Return on Assets: 3.95%

Debt

• Debt-to-Equity Ratio: 0.74
• Current Ratio: 0.87
• Quick Ratio: 0.66

Sales & Book Value

• Annual Sales: $402.07 billion
• Price / Sales: 0.28
• Cash Flow: $14.66 per share
• Price / Cash Flow: 6.04
• Book Value: $59.38 per share
• Price / Book: 1.49

Miscellaneous

• Outstanding Shares: 1,278,970,000
• Free Float: 1,268,099,000
• Market Cap: $113.24 billion
• Optionable: Optionable
• Beta: 0.60